Transdermal Drug Delivery System Market - Global Outlook and Forecast 2021-2027

January 2021 | 106 pages | ID: T45CA2D07BA5EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Transdermal Drug Delivery System in Global, including the following market information:
Global Transdermal Drug Delivery System Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Transdermal Drug Delivery System market was valued at 13670 million in 2020 and is projected to reach US$ 22080 million by 2027, at a CAGR of 12.7% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Transdermal Drug Delivery System companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Transdermal Drug Delivery System Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Transdermal Drug Delivery System Market Segment Percentages, By Type, 2020 (%)

• Fentanyl
• Nitroglycerin
• Estradiol
• Nicotine
• Other

China Transdermal Drug Delivery System Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Transdermal Drug Delivery System Market Segment Percentages, By Application, 2020 (%)

• OTC
• Rx

Global Transdermal Drug Delivery System Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Transdermal Drug Delivery System Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Transdermal Drug Delivery System Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Transdermal Drug Delivery System Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• Hisamitsu
• Mylan
• GSK
• Novartis
• Teve (Actavis)
• Johnson & Johnson
• Lohmann
• Teikoku Seiyaku
• Bayer
• Lingrui
• Sanofi
• Qizheng
• Endo
• Huarun 999
• Haw Par
• Nichiban
• Mentholatum
• Laboratoires Genevrier

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Transdermal Drug Delivery System Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Transdermal Drug Delivery System Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM OVERALL MARKET SIZE

2.1 Global Transdermal Drug Delivery System Market Size: 2021 VS 2027
2.2 Global Transdermal Drug Delivery System Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Transdermal Drug Delivery System Players in Global Market
3.2 Top Global Transdermal Drug Delivery System Companies Ranked by Revenue
3.3 Global Transdermal Drug Delivery System Revenue by Companies
3.4 Top 3 and Top 5 Transdermal Drug Delivery System Companies in Global Market, by Revenue in 2020
3.5 Global Companies Transdermal Drug Delivery System Product Type
3.6 Tier 1, Tier 2 and Tier 3 Transdermal Drug Delivery System Players in Global Market
  3.6.1 List of Global Tier 1 Transdermal Drug Delivery System Companies
  3.6.2 List of Global Tier 2 and Tier 3 Transdermal Drug Delivery System Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Transdermal Drug Delivery System Market Size Markets, 2021 & 2027
  4.1.2 Fentanyl
  4.1.3 Nitroglycerin
  4.1.4 Estradiol
  4.1.5 Nicotine
  4.1.6 Other
4.2 By Type - Global Transdermal Drug Delivery System Revenue & Forecasts
  4.2.1 By Type - Global Transdermal Drug Delivery System Revenue, 2016-2021
  4.2.2 By Type - Global Transdermal Drug Delivery System Revenue, 2022-2027
  4.2.3 By Type - Global Transdermal Drug Delivery System Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Transdermal Drug Delivery System Market Size, 2021 & 2027
  5.1.2 OTC
  5.1.3 Rx
5.2 By Application - Global Transdermal Drug Delivery System Revenue & Forecasts
  5.2.1 By Application - Global Transdermal Drug Delivery System Revenue, 2016-2021
  5.2.2 By Application - Global Transdermal Drug Delivery System Revenue, 2022-2027
  5.2.3 By Application - Global Transdermal Drug Delivery System Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Transdermal Drug Delivery System Market Size, 2021 & 2027
6.2 By Region - Global Transdermal Drug Delivery System Revenue & Forecasts
  6.2.1 By Region - Global Transdermal Drug Delivery System Revenue, 2016-2021
  6.2.2 By Region - Global Transdermal Drug Delivery System Revenue, 2022-2027
  6.2.3 By Region - Global Transdermal Drug Delivery System Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Transdermal Drug Delivery System Revenue, 2016-2027
  6.3.2 US Transdermal Drug Delivery System Market Size, 2016-2027
  6.3.3 Canada Transdermal Drug Delivery System Market Size, 2016-2027
  6.3.4 Mexico Transdermal Drug Delivery System Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Transdermal Drug Delivery System Revenue, 2016-2027
  6.4.2 Germany Transdermal Drug Delivery System Market Size, 2016-2027
  6.4.3 France Transdermal Drug Delivery System Market Size, 2016-2027
  6.4.4 U.K. Transdermal Drug Delivery System Market Size, 2016-2027
  6.4.5 Italy Transdermal Drug Delivery System Market Size, 2016-2027
  6.4.6 Russia Transdermal Drug Delivery System Market Size, 2016-2027
  6.4.7 Nordic Countries Transdermal Drug Delivery System Market Size, 2016-2027
  6.4.8 Benelux Transdermal Drug Delivery System Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Transdermal Drug Delivery System Revenue, 2016-2027
  6.5.2 China Transdermal Drug Delivery System Market Size, 2016-2027
  6.5.3 Japan Transdermal Drug Delivery System Market Size, 2016-2027
  6.5.4 South Korea Transdermal Drug Delivery System Market Size, 2016-2027
  6.5.5 Southeast Asia Transdermal Drug Delivery System Market Size, 2016-2027
  6.5.6 India Transdermal Drug Delivery System Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Transdermal Drug Delivery System Revenue, 2016-2027
  6.6.2 Brazil Transdermal Drug Delivery System Market Size, 2016-2027
  6.6.3 Argentina Transdermal Drug Delivery System Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Transdermal Drug Delivery System Revenue, 2016-2027
  6.7.2 Turkey Transdermal Drug Delivery System Market Size, 2016-2027
  6.7.3 Israel Transdermal Drug Delivery System Market Size, 2016-2027
  6.7.4 Saudi Arabia Transdermal Drug Delivery System Market Size, 2016-2027
  6.7.5 UAE Transdermal Drug Delivery System Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Hisamitsu
  7.1.1 Hisamitsu Corporate Summary
  7.1.2 Hisamitsu Business Overview
  7.1.3 Hisamitsu Transdermal Drug Delivery System Major Product Offerings
  7.1.4 Hisamitsu Transdermal Drug Delivery System Revenue in Global (2016-2021)
  7.1.5 Hisamitsu Key News
7.2 Mylan
  7.2.1 Mylan Corporate Summary
  7.2.2 Mylan Business Overview
  7.2.3 Mylan Transdermal Drug Delivery System Major Product Offerings
  7.2.4 Mylan Transdermal Drug Delivery System Revenue in Global (2016-2021)
  7.2.5 Mylan Key News
7.3 GSK
  7.3.1 GSK Corporate Summary
  7.3.2 GSK Business Overview
  7.3.3 GSK Transdermal Drug Delivery System Major Product Offerings
  7.3.4 GSK Transdermal Drug Delivery System Revenue in Global (2016-2021)
  7.3.5 GSK Key News
7.4 Novartis
  7.4.1 Novartis Corporate Summary
  7.4.2 Novartis Business Overview
  7.4.3 Novartis Transdermal Drug Delivery System Major Product Offerings
  7.4.4 Novartis Transdermal Drug Delivery System Revenue in Global (2016-2021)
  7.4.5 Novartis Key News
7.5 Teve (Actavis)
  7.5.1 Teve (Actavis) Corporate Summary
  7.5.2 Teve (Actavis) Business Overview
  7.5.3 Teve (Actavis) Transdermal Drug Delivery System Major Product Offerings
  7.5.4 Teve (Actavis) Transdermal Drug Delivery System Revenue in Global (2016-2021)
  7.5.5 Teve (Actavis) Key News
7.6 Johnson & Johnson
  7.6.1 Johnson & Johnson Corporate Summary
  7.6.2 Johnson & Johnson Business Overview
  7.6.3 Johnson & Johnson Transdermal Drug Delivery System Major Product Offerings
  7.6.4 Johnson & Johnson Transdermal Drug Delivery System Revenue in Global (2016-2021)
  7.6.5 Johnson & Johnson Key News
7.7 Lohmann
  7.7.1 Lohmann Corporate Summary
  7.7.2 Lohmann Business Overview
  7.7.3 Lohmann Transdermal Drug Delivery System Major Product Offerings
  7.4.4 Lohmann Transdermal Drug Delivery System Revenue in Global (2016-2021)
  7.7.5 Lohmann Key News
7.8 Teikoku Seiyaku
  7.8.1 Teikoku Seiyaku Corporate Summary
  7.8.2 Teikoku Seiyaku Business Overview
  7.8.3 Teikoku Seiyaku Transdermal Drug Delivery System Major Product Offerings
  7.8.4 Teikoku Seiyaku Transdermal Drug Delivery System Revenue in Global (2016-2021)
  7.8.5 Teikoku Seiyaku Key News
7.9 Bayer
  7.9.1 Bayer Corporate Summary
  7.9.2 Bayer Business Overview
  7.9.3 Bayer Transdermal Drug Delivery System Major Product Offerings
  7.9.4 Bayer Transdermal Drug Delivery System Revenue in Global (2016-2021)
  7.9.5 Bayer Key News
7.10 Lingrui
  7.10.1 Lingrui Corporate Summary
  7.10.2 Lingrui Business Overview
  7.10.3 Lingrui Transdermal Drug Delivery System Major Product Offerings
  7.10.4 Lingrui Transdermal Drug Delivery System Revenue in Global (2016-2021)
  7.10.5 Lingrui Key News
7.11 Sanofi
  7.11.1 Sanofi Corporate Summary
  7.11.2 Sanofi Business Overview
  7.11.3 Sanofi Transdermal Drug Delivery System Major Product Offerings
  7.11.4 Sanofi Transdermal Drug Delivery System Revenue in Global (2016-2021)
  7.11.5 Sanofi Key News
7.12 Qizheng
  7.12.1 Qizheng Corporate Summary
  7.12.2 Qizheng Business Overview
  7.12.3 Qizheng Transdermal Drug Delivery System Major Product Offerings
  7.12.4 Qizheng Transdermal Drug Delivery System Revenue in Global (2016-2021)
  7.12.5 Qizheng Key News
7.13 Endo
  7.13.1 Endo Corporate Summary
  7.13.2 Endo Business Overview
  7.13.3 Endo Transdermal Drug Delivery System Major Product Offerings
  7.13.4 Endo Transdermal Drug Delivery System Revenue in Global (2016-2021)
  7.13.5 Endo Key News
7.14 Huarun
  7.14.1 Huarun 999 Corporate Summary
  7.14.2 Huarun 999 Business Overview
  7.14.3 Huarun 999 Transdermal Drug Delivery System Major Product Offerings
  7.14.4 Huarun 999 Transdermal Drug Delivery System Revenue in Global (2016-2021)
  7.14.5 Huarun 999 Key News
7.15 Haw Par
  7.15.1 Haw Par Corporate Summary
  7.15.2 Haw Par Business Overview
  7.15.3 Haw Par Transdermal Drug Delivery System Major Product Offerings
  7.15.4 Haw Par Transdermal Drug Delivery System Revenue in Global (2016-2021)
  7.15.5 Haw Par Key News
7.16 Nichiban
  7.16.1 Nichiban Corporate Summary
  7.16.2 Nichiban Business Overview
  7.16.3 Nichiban Transdermal Drug Delivery System Major Product Offerings
  7.16.4 Nichiban Transdermal Drug Delivery System Revenue in Global (2016-2021)
  7.16.5 Nichiban Key News
7.17 Mentholatum
  7.17.1 Mentholatum Corporate Summary
  7.17.2 Mentholatum Business Overview
  7.17.3 Mentholatum Transdermal Drug Delivery System Major Product Offerings
  7.17.4 Mentholatum Transdermal Drug Delivery System Revenue in Global (2016-2021)
  7.17.5 Mentholatum Key News
7.18 Laboratoires Genevrier
  7.18.1 Laboratoires Genevrier Corporate Summary
  7.18.2 Laboratoires Genevrier Business Overview
  7.18.3 Laboratoires Genevrier Transdermal Drug Delivery System Major Product Offerings
  7.18.4 Laboratoires Genevrier Transdermal Drug Delivery System Revenue in Global (2016-2021)
  7.18.5 Laboratoires Genevrier Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Transdermal Drug Delivery System Market Opportunities & Trends in Global Market
Table 2. Transdermal Drug Delivery System Market Drivers in Global Market
Table 3. Transdermal Drug Delivery System Market Restraints in Global Market
Table 4. Key Players of Transdermal Drug Delivery System in Global Market
Table 5. Top Transdermal Drug Delivery System Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Transdermal Drug Delivery System Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Transdermal Drug Delivery System Revenue Share by Companies, 2016-2021
Table 8. Global Companies Transdermal Drug Delivery System Product Type
Table 9. List of Global Tier 1 Transdermal Drug Delivery System Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Transdermal Drug Delivery System Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Transdermal Drug Delivery System Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Transdermal Drug Delivery System Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Transdermal Drug Delivery System Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Transdermal Drug Delivery System Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Transdermal Drug Delivery System Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Transdermal Drug Delivery System Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Transdermal Drug Delivery System Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Transdermal Drug Delivery System Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Transdermal Drug Delivery System Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Transdermal Drug Delivery System Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Transdermal Drug Delivery System Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Transdermal Drug Delivery System Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Transdermal Drug Delivery System Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Transdermal Drug Delivery System Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Transdermal Drug Delivery System Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Transdermal Drug Delivery System Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Transdermal Drug Delivery System Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Transdermal Drug Delivery System Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Transdermal Drug Delivery System Revenue, (US$, Mn), 2022-2027
Table 30. Hisamitsu Corporate Summary
Table 31. Hisamitsu Transdermal Drug Delivery System Product Offerings
Table 32. Hisamitsu Transdermal Drug Delivery System Revenue (US$, Mn), (2016-2021)
Table 33. Mylan Corporate Summary
Table 34. Mylan Transdermal Drug Delivery System Product Offerings
Table 35. Mylan Transdermal Drug Delivery System Revenue (US$, Mn), (2016-2021)
Table 36. GSK Corporate Summary
Table 37. GSK Transdermal Drug Delivery System Product Offerings
Table 38. GSK Transdermal Drug Delivery System Revenue (US$, Mn), (2016-2021)
Table 39. Novartis Corporate Summary
Table 40. Novartis Transdermal Drug Delivery System Product Offerings
Table 41. Novartis Transdermal Drug Delivery System Revenue (US$, Mn), (2016-2021)
Table 42. Teve (Actavis) Corporate Summary
Table 43. Teve (Actavis) Transdermal Drug Delivery System Product Offerings
Table 44. Teve (Actavis) Transdermal Drug Delivery System Revenue (US$, Mn), (2016-2021)
Table 45. Johnson & Johnson Corporate Summary
Table 46. Johnson & Johnson Transdermal Drug Delivery System Product Offerings
Table 47. Johnson & Johnson Transdermal Drug Delivery System Revenue (US$, Mn), (2016-2021)
Table 48. Lohmann Corporate Summary
Table 49. Lohmann Transdermal Drug Delivery System Product Offerings
Table 50. Lohmann Transdermal Drug Delivery System Revenue (US$, Mn), (2016-2021)
Table 51. Teikoku Seiyaku Corporate Summary
Table 52. Teikoku Seiyaku Transdermal Drug Delivery System Product Offerings
Table 53. Teikoku Seiyaku Transdermal Drug Delivery System Revenue (US$, Mn), (2016-2021)
Table 54. Bayer Corporate Summary
Table 55. Bayer Transdermal Drug Delivery System Product Offerings
Table 56. Bayer Transdermal Drug Delivery System Revenue (US$, Mn), (2016-2021)
Table 57. Lingrui Corporate Summary
Table 58. Lingrui Transdermal Drug Delivery System Product Offerings
Table 59. Lingrui Transdermal Drug Delivery System Revenue (US$, Mn), (2016-2021)
Table 60. Sanofi Corporate Summary
Table 61. Sanofi Transdermal Drug Delivery System Product Offerings
Table 62. Sanofi Transdermal Drug Delivery System Revenue (US$, Mn), (2016-2021)
Table 63. Qizheng Corporate Summary
Table 64. Qizheng Transdermal Drug Delivery System Product Offerings
Table 65. Qizheng Transdermal Drug Delivery System Revenue (US$, Mn), (2016-2021)
Table 66. Endo Corporate Summary
Table 67. Endo Transdermal Drug Delivery System Product Offerings
Table 68. Endo Transdermal Drug Delivery System Revenue (US$, Mn), (2016-2021)
Table 69. Huarun 999 Corporate Summary
Table 70. Huarun 999 Transdermal Drug Delivery System Product Offerings
Table 71. Huarun 999 Transdermal Drug Delivery System Revenue (US$, Mn), (2016-2021)
Table 72. Haw Par Corporate Summary
Table 73. Haw Par Transdermal Drug Delivery System Product Offerings
Table 74. Haw Par Transdermal Drug Delivery System Revenue (US$, Mn), (2016-2021)
Table 75. Nichiban Corporate Summary
Table 76. Nichiban Transdermal Drug Delivery System Product Offerings
Table 77. Nichiban Transdermal Drug Delivery System Revenue (US$, Mn), (2016-2021)
Table 78. Mentholatum Corporate Summary
Table 79. Mentholatum Transdermal Drug Delivery System Product Offerings
Table 80. Mentholatum Transdermal Drug Delivery System Revenue (US$, Mn), (2016-2021)
Table 81. Laboratoires Genevrier Corporate Summary
Table 82. Laboratoires Genevrier Transdermal Drug Delivery System Product Offerings
Table 83. Laboratoires Genevrier Transdermal Drug Delivery System Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Transdermal Drug Delivery System Segment by Type
Figure 2. Transdermal Drug Delivery System Segment by Application
Figure 3. Global Transdermal Drug Delivery System Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Transdermal Drug Delivery System Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Transdermal Drug Delivery System Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Transdermal Drug Delivery System Revenue in 2020
Figure 8. By Type - Global Transdermal Drug Delivery System Revenue Market Share, 2016-2027
Figure 9. By Application - Global Transdermal Drug Delivery System Revenue Market Share, 2016-2027
Figure 10. By Region - Global Transdermal Drug Delivery System Revenue Market Share, 2016-2027
Figure 11. By Country - North America Transdermal Drug Delivery System Revenue Market Share, 2016-2027
Figure 12. US Transdermal Drug Delivery System Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Transdermal Drug Delivery System Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Transdermal Drug Delivery System Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Transdermal Drug Delivery System Revenue Market Share, 2016-2027
Figure 16. Germany Transdermal Drug Delivery System Revenue, (US$, Mn), 2016-2027
Figure 17. France Transdermal Drug Delivery System Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Transdermal Drug Delivery System Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Transdermal Drug Delivery System Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Transdermal Drug Delivery System Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Transdermal Drug Delivery System Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Transdermal Drug Delivery System Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Transdermal Drug Delivery System Revenue Market Share, 2016-2027
Figure 24. China Transdermal Drug Delivery System Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Transdermal Drug Delivery System Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Transdermal Drug Delivery System Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Transdermal Drug Delivery System Revenue, (US$, Mn), 2016-2027
Figure 28. India Transdermal Drug Delivery System Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Transdermal Drug Delivery System Revenue Market Share, 2016-2027
Figure 30. Brazil Transdermal Drug Delivery System Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Transdermal Drug Delivery System Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Transdermal Drug Delivery System Revenue Market Share, 2016-2027
Figure 33. Turkey Transdermal Drug Delivery System Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Transdermal Drug Delivery System Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Transdermal Drug Delivery System Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Transdermal Drug Delivery System Revenue, (US$, Mn), 2016-2027
Figure 37. Hisamitsu Transdermal Drug Delivery System Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Mylan Transdermal Drug Delivery System Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. GSK Transdermal Drug Delivery System Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Novartis Transdermal Drug Delivery System Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Teve (Actavis) Transdermal Drug Delivery System Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Johnson & Johnson Transdermal Drug Delivery System Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Lohmann Transdermal Drug Delivery System Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Teikoku Seiyaku Transdermal Drug Delivery System Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Bayer Transdermal Drug Delivery System Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Lingrui Transdermal Drug Delivery System Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Sanofi Transdermal Drug Delivery System Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Qizheng Transdermal Drug Delivery System Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. Endo Transdermal Drug Delivery System Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. Huarun 999 Transdermal Drug Delivery System Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 51. Haw Par Transdermal Drug Delivery System Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 52. Nichiban Transdermal Drug Delivery System Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 53. Mentholatum Transdermal Drug Delivery System Revenue Year Over Year Growth (US$, Mn) & (2016-2021)